Drug · DIN 02411180
VITEKTA
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since January 9, 2017; first marketed April 21, 2015.
- Drug Identification Number (DIN)
- 02411180
- Company (DIN owner)
- Gilead Sciences Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Elvitegravir J05AJ02
- Class
- Human
- Record last updated
- June 16, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| ELVITEGRAVIR | 150 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- August 27, 2013: NOC 14686New Drug Submission (NDS)
Other DINs named VITEKTA
- DIN 02411172 · Cancelled Post Market